Related Experiment Videos
Hypertensive therapy--effect on coronary risk factors
1Department of Medicine, University of Göteborg, Ostra Hospital, Sweden.
Blood Pressure. Supplement
|January 1, 1992
Summary
Antihypertensive drugs like diuretics and beta-blockers may impact coronary risk factors. However, studies show they significantly reduce myocardial infarction (MI) events, especially in elderly patients with isolated systolic hypertension.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Antihypertensive medications, including diuretics and beta-blockers, can negatively affect coronary risk factors such as plasma lipids.
- This raises concerns that the benefits of blood pressure reduction might be counteracted by adverse effects on these surrogate markers.
Purpose of the Study:
- To evaluate the clinical impact of antihypertensive agents on actual cardiovascular events, rather than relying solely on surrogate markers.
- To assess whether the observed changes in coronary risk factors translate into meaningful clinical outcomes.
Main Methods:
- Review of studies investigating the effects of diuretics and beta-blockers on myocardial infarction (MI) frequency.
- Analysis of clinical trial data, particularly focusing on elderly patients with isolated systolic hypertension.
Main Results:
- Propranolol (a beta-blocker) significantly reduced the occurrence of myocardial infarction (MI), confirmed by ECG Q-wave evidence.
- Diuretics demonstrated a significant reduction in clinical MI frequency among elderly individuals with isolated systolic hypertension.
Conclusions:
- The use of surrogate markers like plasma lipids may be inappropriate for assessing the overall benefit of certain antihypertensive agents.
- Diuretics and beta-blockers provide significant cardiovascular protection by reducing myocardial infarction events, particularly in specific patient populations.